483
Lonza AGLonza AG – FDA 483, Mar 29, 2019
Record Details
Lona Pharma and Biotech in Visp, Switzerland, a drug substance manufacturer, was cited with five observations during an FDA inspection from March 25-29, 2019. The observations primarily concern inadequate testing and storage of intermediates and drug substances, deficiencies in validation studies, and issues with raw material handling, pest control, and QC analytical procedures. These findings indicate significant concerns regarding quality control and manufacturing practices.
View Company Profile
ID · d2b94531-82a9-47ee-8dfc-06a69d21c1c6
Other documents for Lonza AG
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.